Medimaps Group Raises $20 Million To Expand And To Commercialize Ai Product Portfolio For Bone Health Assessment Utilizing Routine Medical Images
Amount Raised
$20 Million
Round Type
Funding Round
GenevaManufacturingBiotechnologyData And AnalyticsHealth CareMedicalMedical DeviceDescription
MEDIMAPS GROUP, (www.medimapsgroup.com), a Swiss/Global med-tech company specializing in image processing software for the assessment of bone health, announced today that it has secured $20 million in an institutional investment round led by Swisscanto Invest by Zürcher Kantonalbank, alongside Swiss Entrepreneurs Fund, Swisscom Ventures, and Verve Ventures. The funds raised will be used to expand its product portfolio with the development and market launch of its patented A.I. applications for bone health assessment in the U.S., Europe, Asia, and Latin America. The company’s current flagship product, Trabecular Bone Score (TBS iNsight), has received medical reimbursement in the U.S
Who to call at medimaps group S.A, and when
A new round usually means medimaps group S.A is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day medimaps group S.A raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at medimaps group S.A, from your own LinkedIn network
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment medimaps group S.A raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
medimaps group S.A raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.